Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baheal Pharmaceutical Group is a leading Chinese healthcare enterprise specializing in the commercialization of innovative drugs and health products. The company operates a comprehensive ecosystem that integrates research and development, advanced manufacturing, and a sophisticated multi-channel distribution network. Baheal is best known for its robust commercialization platform, which assists global pharmaceutical companies in navigating the Chinese market and scaling their product reach. Their portfolio covers a wide range of therapeutic areas, including oncology, cardiovascular disease, and chronic care management, supported by digital health and AI-driven marketing solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BAHEAL Pharmaceutical Holdings.